Oncolytics Biotech, Inc. (ONCY) stock has risen 146.36% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ONCY stock a score of 76 out of a possible 100.
That rank is mainly influenced by a fundamental score of 98. In addition to the average rating from Wall Street analysts, ONCY stock has a mean target price of 7.713. This means analysts expect the stock to gain 184.61% over the next 12 months. ONCY's rank also includes a long-term technical score of 70. The short-term technical score for ONCY is 60.
What's Happening with ONCY Stock Today
Oncolytics Biotech, Inc. (ONCY) stock is up 3.18% while the S&P 500 has risen 1.64% as of 1:21 PM on Tuesday, Nov 24. ONCY has risen $0.08 from the previous closing price of $2.63 on volume of 1,290,139 shares. Over the past year the S&P 500 has risen 16.04% while ONCY has risen 146.36%. ONCY lost -$0.79 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Oncolytics Biotech, Inc. (ONCY) Stock.
